BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2543687)

  • 1. Effects of thyrotropin-releasing hormone and gonadotropin-releasing hormone on inositol phospholipid turnover in endocrinologically inactive pituitary adenomas and prolactinomas.
    Levy A; Lightman SL
    J Clin Endocrinol Metab; 1989 Jul; 69(1):122-6. PubMed ID: 2543687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol phospholipid turnover and intracellular Ca2+ responses to thyrotrophin-releasing hormone, gonadotrophin-releasing hormone and arginine vasopressin in pituitary corticotroph and somatotroph adenomas.
    Levy A; Lightman SL; Hoyland J; Mason WT
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):73-9. PubMed ID: 2169360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenomas with high and low basal inositol phospholipid turnover; the stimulatory effect of kinins and an association with interleukin-6 secretion.
    Jones TH; Kennedy RL; Justice SK; Price A
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):433-9. PubMed ID: 8287569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gonadotropin-releasing hormone (GnRH) antagonist distinguishes three populations of GnRH analog-responsive cells in human and rat pituitary in vitro and produces an acute increase in intracellular Ca2+ concentration without inducing gonadotropin secretion.
    Levy A; Lightman SL; Hoyland J; Rawlings S; Mason WT
    Mol Endocrinol; 1990 May; 4(5):678-84. PubMed ID: 2177142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression study of thyrotropin releasing hormone (TRH) receptor using RT-PCR: relationship to clinical and immunohistochemical phenotypes in a series of human pituitary adenomas.
    Igarashi-Migitaka J; Yamada S; Hara M; Sano T; Ozawa Y; Ohtani-Kaneko R; Hirata K
    Endocr J; 2003 Aug; 50(4):459-67. PubMed ID: 14599121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.
    Kim K; Arai K; Sanno N; Teramoto A; Shibasaki T
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory effect of gonadotropin-releasing hormone (GnRH) on in vitro prolactin secretion and presence of GnRH specific receptors in a subset of human prolactinomas.
    Brandi AM; Barrande G; Lahlou N; Crumeyrolle M; Berthet M; Leblanc P; Peillon F; Li JY
    Eur J Endocrinol; 1995 Feb; 132(2):163-70. PubMed ID: 7858734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology.
    Asa SL; Cheng Z; Ramyar L; Singer W; Kovacs K; Smyth HS; Muller P
    J Clin Endocrinol Metab; 1992 May; 74(5):1128-34. PubMed ID: 1569159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of bromocriptine, thyrotropin-releasing hormone, and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro.
    Lamberts SW; Verleun T; Oosterom R; Hofland L; van Ginkel LA; Loeber JG; van Vroonhoven CC; Stefanko SZ; de Jong FH
    J Clin Endocrinol Metab; 1987 Mar; 64(3):524-30. PubMed ID: 3102540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered balance between thyrotropin-releasing hormone and dopamine in prolactinomas and other pituitary tumors compared to normal pituitaries.
    Le Dafniet M; Blumberg-Tick J; Gozlan H; Barret A; Joubert Bression D; Peillon F
    J Clin Endocrinol Metab; 1989 Aug; 69(2):267-71. PubMed ID: 2502552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that signalling pathways by which thyrotropin-releasing hormone and gonadotropin-releasing hormone act are both common and distinct.
    Kaiser UB; Katzenellenbogen RA; Conn PM; Chin WW
    Mol Endocrinol; 1994 Aug; 8(8):1038-48. PubMed ID: 7527898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: cloning and functional expression of the human thyrotropin-releasing hormone receptor gene.
    Yamada M; Monden T; Satoh T; Satoh N; Murakami M; Iriuchijima T; Kakegawa T; Mori M
    Biochem Biophys Res Commun; 1993 Sep; 195(2):737-45. PubMed ID: 8396925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone regulates gonadotropin beta-subunit and chromogranin-B messenger ribonucleic acids in cultured chromogranin-A-positive pituitary adenomas.
    Song JY; Jin L; Chandler WF; England BG; Smart JB; Landefeld TD; Lloyd RV
    J Clin Endocrinol Metab; 1990 Sep; 71(3):622-30. PubMed ID: 2118538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin-releasing hormone and gonadotropin-releasing hormone-associated peptide modulation of [Ca2+]i in human lactotrophs.
    Dufy-Barbe L; Bresson L; Vacher P; Odessa MF; San Galli F; Rivel J; Guérin J
    Mol Cell Endocrinol; 1993 Sep; 95(1-2):67-74. PubMed ID: 8243809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic peptides modulate cytosolic free Ca2+ levels and adenylyl cyclase activity in human nonfunctioning pituitary adenomas.
    Spada A; Reza-Elahi F; Lania A; Gil-del-Alamo P; Bassetti M; Faglia G
    J Clin Endocrinol Metab; 1991 Oct; 73(4):913-8. PubMed ID: 1679762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of thyrotropin-releasing hormone (TRH) and TRH-binding sites in human nonsecreting pituitary adenomas.
    Le Dafniet M; Grouselle D; Li JY; Kujas M; Bression D; Barret A; Tixier-Vidal A; Peillon F
    J Clin Endocrinol Metab; 1987 Nov; 65(5):1014-9. PubMed ID: 3117830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative in-situ hybridization histochemistry of anterior pituitary hormone mRNA species in human pituitary adenomas.
    Levy A; Lightman SL
    Acta Endocrinol (Copenh); 1988 Nov; 119(3):397-404. PubMed ID: 3188812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries.
    Sanno N; Jin L; Qian X; Osamura RY; Scheithauer BW; Kovacs K; Lloyd RV
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1974-82. PubMed ID: 9177416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreastatin secretion by pituitary adenomas and regulation of chromogranin B mRNA expression.
    Jin L; Scheithauer BW; Young WF; Davis DH; Klee GG; Lloyd RV
    Am J Pathol; 1996 Jun; 148(6):2057-66. PubMed ID: 8669489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.